GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
PCE(x) | 49.02 | 49.90 | 33.31 | 62.75 | 66.69 |
What is the latest Price to Cash Earnings (PCE) ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Price to Cash Earnings (PCE) |
---|---|
Mar2025 | 49.02 |
Mar2024 | 49.90 |
Mar2023 | 33.31 |
Mar2022 | 62.75 |
Mar2021 | 66.69 |
How is Price to Cash Earnings (PCE) of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Price to Cash Earnings (PCE) | % Change | |
---|---|---|---|
Mar2025 | 49.02 | -1.76 | |
Mar2024 | 49.9 | 49.80 | |
Mar2023 | 33.31 | -46.92 | |
Mar2022 | 62.75 | -5.91 | |
Mar2021 | 66.69 | - |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹52,807.1 Cr | -2.6% | -2.7% | 22.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -2.6% |
-2.7% |
22.6% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses